<html>
<head>
<title>Rai Lab | People</title>
<link rel="stylesheet" type="text/css" href="stylesheet.css">
<link href='https://fonts.googleapis.com/css?family=Roboto+Condensed' rel='stylesheet' type='text/css'>
<link href='https://fonts.googleapis.com/css?family=Roboto' rel='stylesheet' type='text/css'>
</head>
<body>
<br>
<div id="all">
<div id="logo">
<a href="index.html"><img src="logo.png" height=105px"></a>
</div>
<div id="navbar">
<br><br><br><br>
<a href="research.html">research</a>&nbsp;&nbsp;&nbsp;|
&nbsp;&nbsp;&nbsp;<a href="people.html">people</a>&nbsp;&nbsp;&nbsp;|
&nbsp;&nbsp;&nbsp;<a href="publications.html">publications</a>&nbsp;&nbsp;&nbsp;
|&nbsp;&nbsp;&nbsp;<a href="photos.html">photos</a>&nbsp;&nbsp;&nbsp;|&nbsp;&nbsp;&nbsp;<a href="contact.html">contact</a>
</div>
<br><br><br><br><br><br>
<div id="main">
<div id="title">
People
</div>
<div id="text">
<h3>Principal Investigator</h3>
<table class="people">
<col width="20%">
<col width="0%">
<tr>
	<td><img src="kunal.jpg" style="border-radius:5px" width="100%">
	<td><h3>Kunal Rai, PhD</h3><font size="3em"><br>Assistant Professor<br>Department of Genomic Medicine</font>
</table>
<h3>Postdoctoral Fellows</h3>
<table class="people">
<col width="20%">
<col width="0%">
<tr>
	<td><img src="mahi.jpg" style="border-radius:5px" width="100%">
	<td><h3>Mayinuer Maitituoheti, MD, PhD</h3></h3>

<font size="2em">(alternative spelling: Mahinur Mattohti)<br><br>I joined the Wall Lab at Harvard Medical School on 2011 as a visiting scholar when I was pursuing my PhD in HUST, China. After finished my PhD, I started my postdoc research at Harvard and investigated cancer genomics research, with a focus on the clinical impact of whole-genomic data in personalized medicine and genomic pathology. At the Rai lab, I engaged in the cancer epigenomics research which focused on understanding the role of epigenome in cancer progression and epigenetic basis for immunotherapy responses. My research goal is to develop systematic approaches to discover and characterize genomic and epigenetic changes that program cancer development in order to derive a deeper understanding of the molecular networks that lead to malignant transformation and to drive the translation of these findings into clinically useful therapeutics. </font>
<tr>
	<td>Photo
	<td><h3>Christopher Terranova, PhD</h3><br>

<font size="2em">Description</font>
<tr>
	<td><img src="elias.png" style="border-radius:5px" width="100%">
	<td><h3>Elias Orouji, MD, PhD</h3><br>

<font size="2em">I am a physician and genomic medicine cancer specialist, currently working as a postdoctoral fellow at the University of Texas MD Anderson Cancer Center. I am a graduate of Heidelberg University, Germany and a member of American Society of Clinical Oncology. My research interests include genomic/epigenomic regulations in different types of cancer, targeted therapies and application of precision medicine in the treatment of cancer.</font>
<tr>
	<td><img src="veena.jpg" style="border-radius:5px" width="100%">
	<td><h3>Veena Kochat, PhD</h3><br>

<font size="2em">We are currently examining the various epigenomic factors that drive the transformation of neurofibroma to malignant peripheral nerve sheath tumor in Type I neurofibromatosis patients by high throughput sequencing studies. We are interested in exploring the non-canonical PRC2-independent role of EZH2 in activating oncogenic signaling pathways in MPNST. Our study aims to develop a combinational therapeutic approach involving epigenetic inhibitors and non-canonical EZH2-mediated signaling pathway inhibitors for MPNST patient cohorts.</font>
<tr>
	<td><img src="zhiyi.jpg" style="border-radius:5px" width="100%">
	<td><h3>Zhiyi Liu, PhD</h3><br>

<font size="2em">I focused on identifying the epigenetic drivers of the tumorigenesis of head and neck squamous cell carcinomas (HNSCCs). The genetic alterations of the <i>TP53</i> gene (encoding p53 the "genome guardian") play the most important role in the malignant transformation of the head and neck squamous cells. A majority of HNSCC tumors (80%) has mutated <i>TP53</i>. Understanding the epigenetic regulations in the contexts of different types of <i>TP53</i> mutations in HNSCC tumors will help us to identify novel therapeutic targets for anticancer treatment against HNSCCs.</font>
</table>
<h3>Research Assistants</h3>
<table class="people">
<tr>
	<td>Photo
	<td><h3>Mayura Dhamdhere</h3><br>Lab Manager

</table>
<h3>Graduate Students</h3>
<table class="people">
<col width="20%">
<col width="0%">
<tr>
	<td><img src="ayush.jpeg" style="border-radius:5px" width="100%">
	<td><h3>Ayush Raman</h3><br>Baylor College of Medicine and MD Anderson Cancer Center
</table>
<h3>Summer Students</h3>
<table class="people">
<col width="20%">
<col width="0%">
<tr>
	<td><img src="james.jpg" style="border-radius:5px" width="100%">
	<td><h3>James Jusuf</h3><font size="3em">High School Student</font><br><br>

<font size="2em">I am examining the functions of CTCF sites and topological domain boundaries in regulating the expression of <i>LARGE</i> in melanoma. I am also testing the effectiveness of targeting CRISPR Cas9-mediated silencing mechanisms to enhancer and promoter regions of genes with copy number amplifications in lung cancer cell lines.</font>
</table>
<h3>Collaborators</h3>
<table class="people">
<col width="20%">
<col width="0%">
<tr>
	<td><img src="ming.jpg" style="border-radius:5px" width="100%">
	<td><h3>Ming Tommy Tang, PhD</h3><font size="3em">Computational Biologist<br>Verhaak Lab</font><br><br>
<a href="http://odin.mdacc.tmc.edu/~rverhaak/people/m_tang/"><font color="#3366BB">Webpage</font></a>
<tr>
	<td><img src="samir.png" style="border-radius:5px" width="100%">
	<td><h3>Samir B. Amin, MBBS</h3><font size="3em">Computational Biologist<br>Verhaak Lab</font><br><br>
<a href="http://odin.mdacc.tmc.edu/~rverhaak/people/s_amin/"><font color="#3366BB">Webpage</font></a>
</table>
</div>
</div>
<div id="footer">
<br>
&copy; 2016 The Rai Lab
</div>
</div>
</body>
</html>